Camlin Fine Sciences Ltd — Regulatory Filings 2021

Dec 31, 2021

==> picture [100 x 31] intentionally omitted <==

December 31, 2021

|To,BSE Limited,25, P. J. Towers,Dalal Street,Mumbai – 400 001**Ref:**Company Scrip Code: 532834|To,Listing Department,National Stock Exchange of India Ltd.,Exchange Plaza, Bandra Kurla Complex,Bandra (East), Mumbai‐ 400051**Ref:Symbol:**CAMLINFINE || Series: EQ| |---|---|

Sub: Intimation of Schedule of Analyst/Investor Meeting(s) pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

We wish to inform you that pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR”), the schedule of Analyst or Investor Meeting(s) to discuss about the Company’s business and about the industry is as under:

Advance Intimation of upcoming Analyst or Investor Meeting(s)

Advance Intimation of upcoming Analyst or Investor Meeting(s)	Advance Intimation of upcoming Analyst or Investor Meeting(s)	Advance Intimation of upcoming Analyst or Investor Meeting(s)	Advance Intimation of upcoming Analyst or Investor Meeting(s)
Sr. No.	Date	Interaction with	Type of Interaction / Medium
1.	January 4, 2022	Various Analysts/Investors	1x1 / group meeting (Virtual)
2.	January 5, 2022
3.	January 6, 2022

Note : The dates of the scheduled call(s) are subject to change due to exigencies on the part of Investors/Company.

Discussions will be based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.

We request you to take the above on record and the same be treated as compliance under the applicable Regulations of SEBI LODR.

Thanking You, Encl.: a/a. For Camlin Fine Sciences Limited

==> picture [54 x 53] intentionally omitted <==

==> picture [79 x 35] intentionally omitted <==

Rahul Sawale Company Secretary & VP Legal

==> picture [426 x 57] intentionally omitted <==